IMP
Process View
regulation of peptidyl tyrosine phosphorylation
Any process that modulates the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of peptidyl tyrosine phosphorylation"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| EGFR | epidermal growth factor receptor | 1.000 | ||
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 1.000 | Human | |
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 1.000 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 1.000 | Human Fly | |
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 1.000 | Human | |
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 1.000 | Human Rat | |
| GRB2 | growth factor receptor-bound protein 2 | 1.000 | Fly | |
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.999 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.999 | Human | |
| PLCG1 | phospholipase C, gamma 1 | 0.997 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.996 | Human | |
| SYK | spleen tyrosine kinase | 0.996 | Mouse | |
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.995 | ||
| GHR | growth hormone receptor | 0.988 | Mouse | |
| FGFR2 | fibroblast growth factor receptor 2 | 0.981 | Human | |
| PTPRC | protein tyrosine phosphatase, receptor type, C | 0.976 | Mouse | |
| NCK1 | NCK adaptor protein 1 | 0.974 | ||
| BTK | Bruton agammaglobulinemia tyrosine kinase | 0.972 | Human | |
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.967 | ||
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.965 | ||
| LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.965 | ||
| FGF1 | fibroblast growth factor 1 (acidic) | 0.952 | Human | |
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.941 | Human Mouse | |
| WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.934 | ||
| LCK | lymphocyte-specific protein tyrosine kinase | 0.926 | Human Mouse | |
| GRB7 | growth factor receptor-bound protein 7 | 0.924 | ||
| TEK | TEK tyrosine kinase, endothelial | 0.921 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.918 | ||
| FHL2 | four and a half LIM domains 2 | 0.917 | ||
| VEGFA | vascular endothelial growth factor A | 0.915 | ||
| FN1 | fibronectin 1 | 0.891 | ||
| LAT | linker for activation of T cells | 0.889 | ||
| SPRR2A | small proline-rich protein 2A | 0.885 | ||
| VAV1 | vav 1 guanine nucleotide exchange factor | 0.884 | ||
| TRAF2 | TNF receptor-associated factor 2 | 0.879 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.861 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.852 | ||
| PTK2 | PTK2 protein tyrosine kinase 2 | 0.845 | Human | |
| MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.825 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.812 | Human | |
| BIRC3 | baculoviral IAP repeat containing 3 | 0.812 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.810 | ||
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.809 | ||
| PLAU | plasminogen activator, urokinase | 0.806 | Human | |
| BCL2 | B-cell CLL/lymphoma 2 | 0.794 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.787 | Human | |
| ICAM1 | intercellular adhesion molecule 1 | 0.785 | ||
| IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 0.772 | ||
| CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.754 | ||
| ZAP70 | zeta-chain (TCR) associated protein kinase 70kDa | 0.745 | ||
| NRP1 | neuropilin 1 | 0.725 | ||
| KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.723 | ||
| NCKAP1 | NCK-associated protein 1 | 0.712 | ||
| ESR1 | estrogen receptor 1 | 0.710 | ||
| SOCS1 | suppressor of cytokine signaling 1 | 0.709 | Human Mouse | |
| SNX9 | sorting nexin 9 | 0.700 | ||
| EZR | ezrin | 0.682 | Human | |
| AXL | AXL receptor tyrosine kinase | 0.658 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.655 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.653 | ||
| FADD | Fas (TNFRSF6)-associated via death domain | 0.615 | ||
| BLNK | B-cell linker | 0.610 | ||
| EPHA2 | EPH receptor A2 | 0.609 | Human | |
| CDC37 | cell division cycle 37 homolog (S. cerevisiae) | 0.607 | ||
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.606 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.602 | ||
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.591 | Human | |
| IER3 | immediate early response 3 | 0.571 | ||
| PAK2 | p21 protein (Cdc42/Rac)-activated kinase 2 | 0.566 | ||
| MTOR | mechanistic target of rapamycin (serine/threonine kinase) | 0.548 | Mouse | |
| CCR5 | chemokine (C-C motif) receptor 5 | 0.542 | ||
| TRADD | TNFRSF1A-associated via death domain | 0.534 | ||
| TAL1 | T-cell acute lymphocytic leukemia 1 | 0.527 | ||
| CD44 | CD44 molecule (Indian blood group) | 0.527 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.522 | ||
| NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.516 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.514 | Human | |
| ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.502 | ||
| RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.492 | ||
| TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.489 | Human | |
| MPDZ | multiple PDZ domain protein | 0.488 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.485 | Human | |
| SH3BP2 | SH3-domain binding protein 2 | 0.482 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.478 | ||
| CD28 | CD28 molecule | 0.467 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.466 | ||
| FLNA | filamin A, alpha | 0.461 | ||
| ENG | endoglin | 0.456 | ||
| RIN1 | Ras and Rab interactor 1 | 0.453 | ||
| YAP1 | Yes-associated protein 1 | 0.439 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.426 | ||
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.419 | ||
| CSH1 | chorionic somatomammotropin hormone 1 (placental lactogen) | 0.416 | Human | |
| APBB1 | amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) | 0.395 | ||
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.391 | Human | |
| SH2D4A | SH2 domain containing 4A | 0.390 | ||
| IL8 | interleukin 8 | 0.389 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.388 | Human | |
| ITGB2 | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) | 0.385 | ||
| PTPN11 | protein tyrosine phosphatase, non-receptor type 11 | 0.380 | Human | |
| ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.380 | Human | |
| MSN | moesin | 0.365 | Human | |
| TNF | tumor necrosis factor | 0.355 | ||
| GH1 | growth hormone 1 | 0.341 | ||
| CFLAR | CASP8 and FADD-like apoptosis regulator | 0.337 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.337 | Human | |
| SH2D1A | SH2 domain containing 1A | 0.336 | ||
| PIK3R2 | phosphoinositide-3-kinase, regulatory subunit 2 (beta) | 0.331 | ||
| MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.330 | ||
| TRAF3 | TNF receptor-associated factor 3 | 0.329 | ||
| EPOR | erythropoietin receptor | 0.328 | ||
| FGF2 | fibroblast growth factor 2 (basic) | 0.327 | Human | |
| LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 0.313 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.312 | ||
| SLA | Src-like-adaptor | 0.302 | ||
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.297 | ||
| THBS1 | thrombospondin 1 | 0.295 | Human | |
| LIFR | leukemia inhibitory factor receptor alpha | 0.293 | Human | |
| JAK1 | Janus kinase 1 | 0.290 | ||
| TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0.277 | Human | |
| CSF2RB | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | 0.273 | ||
| IGF1R | insulin-like growth factor 1 receptor | 0.270 | ||
| BCR | breakpoint cluster region | 0.269 | ||
| PDIA3 | protein disulfide isomerase family A, member 3 | 0.266 | ||
| PTPN23 | protein tyrosine phosphatase, non-receptor type 23 | 0.261 | ||
| CTLA4 | cytotoxic T-lymphocyte-associated protein 4 | 0.261 | ||
| GH2 | growth hormone 2 | 0.259 | Human | |
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.258 | ||
| TFF1 | trefoil factor 1 | 0.248 | ||
| TNS4 | tensin 4 | 0.246 | ||
| FCGR2A | Fc fragment of IgG, low affinity IIa, receptor (CD32) | 0.242 | ||
| GDF9 | growth differentiation factor 9 | 0.242 | ||
| EPS8 | epidermal growth factor receptor pathway substrate 8 | 0.239 | ||
| GRB10 | growth factor receptor-bound protein 10 | 0.236 | ||
| MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.236 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.234 | ||
| SFN | stratifin | 0.233 | ||
| TRAF5 | TNF receptor-associated factor 5 | 0.231 | ||
| OSMR | oncostatin M receptor | 0.226 | Human | |
| MAGI2 | membrane associated guanylate kinase, WW and PDZ domain containing 2 | 0.221 | ||
| STC1 | stanniocalcin 1 | 0.216 | ||
| ARHGEF7 | Rho guanine nucleotide exchange factor (GEF) 7 | 0.216 | ||
| LRRK2 | leucine-rich repeat kinase 2 | 0.215 | ||
| CD9 | CD9 molecule | 0.214 | Human | |
| PRKCB | protein kinase C, beta | 0.213 | ||
| ABI2 | abl-interactor 2 | 0.207 | ||
| IQGAP1 | IQ motif containing GTPase activating protein 1 | 0.206 | ||
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.206 | ||
| MUC1 | mucin 1, cell surface associated | 0.205 | ||
| IL10 | interleukin 10 | 0.205 | ||
| ARRB1 | arrestin, beta 1 | 0.202 | ||
| PGF | placental growth factor | 0.199 | Human | |
| NRP2 | neuropilin 2 | 0.198 | Human | |
| IL1B | interleukin 1, beta | 0.198 | ||
| DLG1 | discs, large homolog 1 (Drosophila) | 0.196 | ||
| SCHIP1 | schwannomin interacting protein 1 | 0.196 | ||
| CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.195 | ||
| VHL | von Hippel-Lindau tumor suppressor | 0.193 | ||
| ITGAL | integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) | 0.193 | Human | |
| NTRK2 | neurotrophic tyrosine kinase, receptor, type 2 | 0.192 | ||
| CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.191 | ||
| CCL11 | chemokine (C-C motif) ligand 11 | 0.189 | Human | |
| ZNF746 | zinc finger protein 746 | 0.188 | ||
| FGA | fibrinogen alpha chain | 0.187 | ||
| ERBB4 | v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) | 0.184 | ||
| PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.184 | ||
| TBX5 | T-box 5 | 0.184 | ||
| ZNF496 | zinc finger protein 496 | 0.182 | ||
| CSHL1 | chorionic somatomammotropin hormone-like 1 | 0.181 | Human | |
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.178 | ||
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.178 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.176 | ||
| STAT4 | signal transducer and activator of transcription 4 | 0.176 | ||
| FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide | 0.175 | ||
| PRKCZ | protein kinase C, zeta | 0.174 | ||
| NCF1 | neutrophil cytosolic factor 1 | 0.173 | ||
| UBASH3B | ubiquitin associated and SH3 domain containing B | 0.173 | ||
| INHBA | inhibin, beta A | 0.173 | ||
| SHC3 | SHC (Src homology 2 domain containing) transforming protein 3 | 0.169 | ||
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.168 | ||
| CDK11B | cyclin-dependent kinase 11B | 0.167 | ||
| IGFBP3 | insulin-like growth factor binding protein 3 | 0.167 | ||
| ANGPTL4 | angiopoietin-like 4 | 0.165 | ||
| SOS1 | son of sevenless homolog 1 (Drosophila) | 0.160 | ||
| CD2 | CD2 molecule | 0.160 | ||
| PLAT | plasminogen activator, tissue | 0.158 | Human | |
| CSH2 | chorionic somatomammotropin hormone 2 | 0.158 | Human | |
| MED28 | mediator complex subunit 28 | 0.157 | ||
| APBB2 | amyloid beta (A4) precursor protein-binding, family B, member 2 | 0.157 | ||
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.156 | ||
| IL6R | interleukin 6 receptor | 0.154 | ||
| CD247 | CD247 molecule | 0.153 | ||
| NOXA1 | NADPH oxidase activator 1 | 0.152 | ||
| FGF7 | fibroblast growth factor 7 | 0.150 | ||
| EPHA3 | EPH receptor A3 | 0.149 | Human | |
| PIK3R3 | phosphoinositide-3-kinase, regulatory subunit 3 (gamma) | 0.149 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.149 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.148 | ||
| ITGA3 | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | 0.147 | Human | |
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.147 | ||
| TLN1 | talin 1 | 0.144 | ||
| PRKCA | protein kinase C, alpha | 0.144 | Mouse | |
| CCL8 | chemokine (C-C motif) ligand 8 | 0.143 | Human | |
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.143 | ||
| PDCD6IP | programmed cell death 6 interacting protein | 0.143 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.140 | ||
| LDLR | low density lipoprotein receptor | 0.140 | ||
| CSK | c-src tyrosine kinase | 0.139 | ||
| RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.136 | ||
| NKX2-5 | NK2 transcription factor related, locus 5 (Drosophila) | 0.136 | ||
| DCN | decorin | 0.133 | ||
| SORBS3 | sorbin and SH3 domain containing 3 | 0.132 | ||
| MARK2 | MAP/microtubule affinity-regulating kinase 2 | 0.132 | ||
| NCF4 | neutrophil cytosolic factor 4, 40kDa | 0.130 | ||
| YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide | 0.128 | ||
| VAV2 | vav 2 guanine nucleotide exchange factor | 0.128 | ||
| CCR7 | chemokine (C-C motif) receptor 7 | 0.128 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.127 | Mouse | |
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.127 | ||
| TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 | 0.126 | ||
| PTEN | phosphatase and tensin homolog | 0.124 | ||
| PARD3 | par-3 partitioning defective 3 homolog (C. elegans) | 0.124 | ||
| TNC | tenascin C | 0.122 | ||
| FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 0.122 | Human | |
| CXCR4 | chemokine (C-X-C motif) receptor 4 | 0.122 | ||
| TENC1 | tensin like C1 domain containing phosphatase (tensin 2) | 0.122 | ||
| CCL5 | chemokine (C-C motif) ligand 5 | 0.121 | ||
| SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.120 | ||
| STAT5A | signal transducer and activator of transcription 5A | 0.120 | ||
| PRR5 | proline rich 5 (renal) | 0.118 | ||
| ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 0.118 | Human | |
| PSEN2 | presenilin 2 (Alzheimer disease 4) | 0.117 | Mouse | |
| LOXL2 | lysyl oxidase-like 2 | 0.117 | ||
| ANGPT2 | angiopoietin 2 | 0.116 | Human | |
| FRS2 | fibroblast growth factor receptor substrate 2 | 0.116 | ||
| NRG1 | neuregulin 1 | 0.116 | ||
| KHDRBS1 | KH domain containing, RNA binding, signal transduction associated 1 | 0.114 | ||
| DDR2 | discoidin domain receptor tyrosine kinase 2 | 0.114 | ||
| PTPN2 | protein tyrosine phosphatase, non-receptor type 2 | 0.114 | ||
| IL22 | interleukin 22 | 0.113 | ||
| PTPN3 | protein tyrosine phosphatase, non-receptor type 3 | 0.111 | ||
| LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.111 | ||
| ACTB | actin, beta | 0.110 | ||
| ANGPT1 | angiopoietin 1 | 0.110 | ||
| TIRAP | toll-interleukin 1 receptor (TIR) domain containing adaptor protein | 0.110 | ||
| IL4R | interleukin 4 receptor | 0.110 | ||
| JAK3 | Janus kinase 3 | 0.109 | ||
| ANXA5 | annexin A5 | 0.109 | ||
| CSF2 | colony stimulating factor 2 (granulocyte-macrophage) | 0.108 | ||
| XAB2 | XPA binding protein 2 | 0.108 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.108 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.106 | Human | |
| PXN | paxillin | 0.106 | ||
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.105 | ||
| MAP4K1 | mitogen-activated protein kinase kinase kinase kinase 1 | 0.105 | ||
| INSR | insulin receptor | 0.105 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.104 | ||
| EFNA1 | ephrin-A1 | 0.104 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.103 | ||
| PRKCD | protein kinase C, delta | 0.100 | Human Mouse | |
| PLEK | pleckstrin | 0.100 | ||
| HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | 0.100 | ||
| MAGEA11 | melanoma antigen family A, 11 | 0.098 | ||
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.098 | ||
| SELE | selectin E | 0.097 | ||
| CD3E | CD3e molecule, epsilon (CD3-TCR complex) | 0.096 | Mouse | |
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.096 | ||
| PROX1 | prospero homeobox 1 | 0.094 | ||
| IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.094 | ||
| PRRX1 | paired related homeobox 1 | 0.093 | ||
| JAK2 | Janus kinase 2 | 0.093 | Mouse | |
| CSF3 | colony stimulating factor 3 (granulocyte) | 0.093 | ||
| PVRL1 | poliovirus receptor-related 1 (herpesvirus entry mediator C) | 0.092 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.092 | Human | |
| CD86 | CD86 molecule | 0.092 | ||
| IL9 | interleukin 9 | 0.091 | ||
| ANKS1B | ankyrin repeat and sterile alpha motif domain containing 1B | 0.091 | ||
| SORBS2 | sorbin and SH3 domain containing 2 | 0.090 | ||
| CDCP1 | CUB domain containing protein 1 | 0.090 | ||
| MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.090 | ||
| PPP1CB | protein phosphatase 1, catalytic subunit, beta isozyme | 0.090 | ||
| SH2B1 | SH2B adaptor protein 1 | 0.089 | ||
| RAC2 | ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) | 0.089 | ||
| CCL4 | chemokine (C-C motif) ligand 4 | 0.089 | Human | |
| RANBP9 | RAN binding protein 9 | 0.088 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.087 | Human | |
| BIRC2 | baculoviral IAP repeat containing 2 | 0.087 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.087 | ||
| ARL2 | ADP-ribosylation factor-like 2 | 0.087 | ||
| PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.087 | ||
| TP73 | tumor protein p73 | 0.087 | ||
| AKAP12 | A kinase (PRKA) anchor protein 12 | 0.087 | ||
| KITLG | KIT ligand | 0.086 | Mouse | |
| MAPT | microtubule-associated protein tau | 0.086 | ||
| FSTL3 | follistatin-like 3 (secreted glycoprotein) | 0.085 | ||
| STAB1 | stabilin 1 | 0.085 | ||
| EIF3F | eukaryotic translation initiation factor 3, subunit F | 0.084 | ||
| IL1A | interleukin 1, alpha | 0.082 | ||
| NCF2 | neutrophil cytosolic factor 2 | 0.082 | ||
| IRS1 | insulin receptor substrate 1 | 0.082 | ||
| STAT1 | signal transducer and activator of transcription 1, 91kDa | 0.082 | ||
| FGF8 | fibroblast growth factor 8 (androgen-induced) | 0.082 | ||
| FHL1 | four and a half LIM domains 1 | 0.081 | ||
| FOSL1 | FOS-like antigen 1 | 0.081 | ||
| FGF10 | fibroblast growth factor 10 | 0.081 | ||
| NTRK3 | neurotrophic tyrosine kinase, receptor, type 3 | 0.081 | ||
| VCAN | versican | 0.081 | ||
| VEGFC | vascular endothelial growth factor C | 0.080 | Human Mouse | |
| ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.080 | Human | |
| CBX1 | chromobox homolog 1 | 0.080 | ||
| PLCG2 | phospholipase C, gamma 2 (phosphatidylinositol-specific) | 0.080 | ||
| CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.080 | ||
| RTKN | rhotekin | 0.079 | ||
| UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.079 | ||
| PVRL2 | poliovirus receptor-related 2 (herpesvirus entry mediator B) | 0.079 | ||
| CCL13 | chemokine (C-C motif) ligand 13 | 0.077 | Human | |
| CAPN1 | calpain 1, (mu/I) large subunit | 0.077 | ||
| CSF1 | colony stimulating factor 1 (macrophage) | 0.077 | ||
| ACVRL1 | activin A receptor type II-like 1 | 0.077 | ||
| STC2 | stanniocalcin 2 | 0.077 | ||
| PARD6A | par-6 partitioning defective 6 homolog alpha (C. elegans) | 0.077 | ||
| WNT2 | wingless-type MMTV integration site family member 2 | 0.076 | ||
| MMP11 | matrix metallopeptidase 11 (stromelysin 3) | 0.076 | ||
| MMP16 | matrix metallopeptidase 16 (membrane-inserted) | 0.076 | ||
| POLR2A | polymerase (RNA) II (DNA directed) polypeptide A, 220kDa | 0.076 | ||
| PGK1 | phosphoglycerate kinase 1 | 0.075 | ||
| SFRP1 | secreted frizzled-related protein 1 | 0.075 | ||
| SH2D3A | SH2 domain containing 3A | 0.075 | ||
| ADAM10 | ADAM metallopeptidase domain 10 | 0.075 | ||
| CDK9 | cyclin-dependent kinase 9 | 0.075 | ||
| IL2RG | interleukin 2 receptor, gamma | 0.075 | ||
| DKK1 | dickkopf homolog 1 (Xenopus laevis) | 0.074 | ||
| ITGB1BP3 | integrin beta 1 binding protein 3 | 0.074 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.074 | ||
| DUSP23 | dual specificity phosphatase 23 | 0.073 | ||
| HAS2 | hyaluronan synthase 2 | 0.073 | ||
| YWHAB | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide | 0.073 | ||
| VAV3 | vav 3 guanine nucleotide exchange factor | 0.073 | ||
| WASL | Wiskott-Aldrich syndrome-like | 0.073 | ||
| PLOD2 | procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 | 0.072 | ||
| HGF | hepatocyte growth factor (hepapoietin A; scatter factor) | 0.072 | ||
| CSF2RA | colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) | 0.072 | ||
| IL2RA | interleukin 2 receptor, alpha | 0.072 | ||
| NNMT | nicotinamide N-methyltransferase | 0.071 | ||
| GFPT2 | glutamine-fructose-6-phosphate transaminase 2 | 0.070 | ||
| OSM | oncostatin M | 0.069 | ||
| RICTOR | RPTOR independent companion of MTOR, complex 2 | 0.069 | Mouse | |
| ERCC8 | excision repair cross-complementing rodent repair deficiency, complementation group 8 | 0.069 | ||
| LTA | lymphotoxin alpha (TNF superfamily, member 1) | 0.069 | ||
| ITGB4 | integrin, beta 4 | 0.068 | ||
| IL3 | interleukin 3 (colony-stimulating factor, multiple) | 0.067 | ||
| CALR | calreticulin | 0.067 | ||
| THBS2 | thrombospondin 2 | 0.067 | Human | |
| PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.067 | ||
| DLG5 | discs, large homolog 5 (Drosophila) | 0.067 | ||
| CXCL12 | chemokine (C-X-C motif) ligand 12 | 0.067 | ||
| RPTOR | regulatory associated protein of MTOR, complex 1 | 0.067 | ||
| STRADA | STE20-related kinase adaptor alpha | 0.067 | ||
| PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.065 | ||
| FGG | fibrinogen gamma chain | 0.065 | ||
| NTF3 | neurotrophin 3 | 0.065 | ||
| EXT1 | exostosin 1 | 0.065 | ||
| MAPK8IP1 | mitogen-activated protein kinase 8 interacting protein 1 | 0.064 | ||
| FLT4 | fms-related tyrosine kinase 4 | 0.064 | Human | |
| LMO2 | LIM domain only 2 (rhombotin-like 1) | 0.064 | ||
| BAD | BCL2-associated agonist of cell death | 0.064 | ||
| DARC | Duffy blood group, chemokine receptor | 0.064 | ||
| PTAFR | platelet-activating factor receptor | 0.064 | ||
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.063 | ||
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.063 | ||
| EPHB2 | EPH receptor B2 | 0.063 | Human | |
| APOH | apolipoprotein H (beta-2-glycoprotein I) | 0.063 | ||
| STAT6 | signal transducer and activator of transcription 6, interleukin-4 induced | 0.063 | ||
| GAB2 | GRB2-associated binding protein 2 | 0.062 | ||
| IL11 | interleukin 11 | 0.062 | ||
| APP | amyloid beta (A4) precursor protein | 0.062 | Mouse | |
| PTPN22 | protein tyrosine phosphatase, non-receptor type 22 (lymphoid) | 0.062 | ||
| PPHLN1 | periphilin 1 | 0.062 | ||
| FCGR3B | Fc fragment of IgG, low affinity IIIb, receptor (CD16b) | 0.062 | ||
| TFPI | tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) | 0.062 | ||
| BRAF | v-raf murine sarcoma viral oncogene homolog B1 | 0.062 | ||
| PTGER3 | prostaglandin E receptor 3 (subtype EP3) | 0.062 | ||
| F2 | coagulation factor II (thrombin) | 0.062 | ||
| PECAM1 | platelet/endothelial cell adhesion molecule | 0.061 | ||
| TBC1D10A | TBC1 domain family, member 10A | 0.061 | ||
| MAP4K3 | mitogen-activated protein kinase kinase kinase kinase 3 | 0.061 | ||
| BAIAP2 | BAI1-associated protein 2 | 0.061 | ||
| GRN | granulin | 0.061 | ||
| SH3D19 | SH3 domain containing 19 | 0.061 | ||
| CASK | calcium/calmodulin-dependent serine protein kinase (MAGUK family) | 0.061 | ||
| IL32 | interleukin 32 | 0.060 | ||
| IL1R1 | interleukin 1 receptor, type I | 0.060 | ||
| FKBP1A | FK506 binding protein 1A, 12kDa | 0.059 | ||
| LAMC2 | laminin, gamma 2 | 0.059 | ||
| EFNB1 | ephrin-B1 | 0.059 | Human | |
| TLR2 | toll-like receptor 2 | 0.059 | ||
| CD22 | CD22 molecule | 0.058 | ||
| CCL19 | chemokine (C-C motif) ligand 19 | 0.058 | Human | |
| CD274 | CD274 molecule | 0.058 | ||
| SNAI1 | snail homolog 1 (Drosophila) | 0.058 | ||
| GREM1 | gremlin 1 | 0.058 | Mouse | |
| RGS4 | regulator of G-protein signaling 4 | 0.058 | ||
| IL23A | interleukin 23, alpha subunit p19 | 0.058 | ||
| CCKBR | cholecystokinin B receptor | 0.058 | ||
| FGF6 | fibroblast growth factor 6 | 0.058 | Human | |
| PVRL3 | poliovirus receptor-related 3 | 0.057 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.057 | ||
| CD63 | CD63 molecule | 0.057 | ||
| CD37 | CD37 molecule | 0.057 | ||
| BAK1 | BCL2-antagonist/killer 1 | 0.056 | ||
| TCF3 | transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) | 0.056 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.056 | ||
| IFNG | interferon, gamma | 0.056 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.055 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.055 | ||
| DLC1 | deleted in liver cancer 1 | 0.055 | ||
| BDNF | brain-derived neurotrophic factor | 0.055 | Human | |
| FLNB | filamin B, beta | 0.055 | ||
| CD81 | CD81 molecule | 0.055 | ||
| FHL3 | four and a half LIM domains 3 | 0.054 | ||
| CTGF | connective tissue growth factor | 0.054 | ||
| TSPAN4 | tetraspanin 4 | 0.054 | ||
| ADRBK1 | adrenergic, beta, receptor kinase 1 | 0.054 | ||
| IL4 | interleukin 4 | 0.054 | Mouse | |
| BCL2A1 | BCL2-related protein A1 | 0.054 | ||
| TIE1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 | 0.054 | ||
| CD93 | CD93 molecule | 0.053 | ||
| NGFR | nerve growth factor receptor | 0.053 | ||
| ITGA1 | integrin, alpha 1 | 0.053 | Human | |
| EMILIN1 | elastin microfibril interfacer 1 | 0.053 | ||
| SOCS2 | suppressor of cytokine signaling 2 | 0.053 | Human | |
| TGFB3 | transforming growth factor, beta 3 | 0.052 | ||
| YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide | 0.052 | ||
| PARD6B | par-6 partitioning defective 6 homolog beta (C. elegans) | 0.052 | ||
| WIPF1 | WAS/WASL interacting protein family, member 1 | 0.052 | ||
| WNT1 | wingless-type MMTV integration site family, member 1 | 0.052 | ||
| IL7R | interleukin 7 receptor | 0.052 | ||
| FGFR4 | fibroblast growth factor receptor 4 | 0.052 | Human | |
| KRT18 | keratin 18 | 0.052 | ||
| NEDD4 | neural precursor cell expressed, developmentally down-regulated 4 | 0.051 | ||
| ITIH5 | inter-alpha (globulin) inhibitor H5 | 0.051 | ||
| CYTB | cytochrome b | 0.051 | ||
| LY6G6F | lymphocyte antigen 6 complex, locus G6F | 0.051 | ||
| APOE | apolipoprotein E | 0.051 | ||
| MAPK10 | mitogen-activated protein kinase 10 | 0.051 | ||
| NACAD | NAC alpha domain containing | 0.050 | ||
| CCDC6 | coiled-coil domain containing 6 | 0.050 | ||
| COL4A2 | collagen, type IV, alpha 2 | 0.050 | ||
| EPHA7 | EPH receptor A7 | 0.050 | ||
| PLEKHA1 | pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1 | 0.050 | ||
| CCND3 | cyclin D3 | 0.050 | ||
| FZD1 | frizzled homolog 1 (Drosophila) | 0.050 | ||
| SH3RF1 | SH3 domain containing ring finger 1 | 0.049 | ||
| C5AR1 | complement component 5a receptor 1 | 0.049 | ||
| F2RL3 | coagulation factor II (thrombin) receptor-like 3 | 0.049 | ||
| COL14A1 | collagen, type XIV, alpha 1 | 0.049 | ||
| SH3PXD2A | SH3 and PX domains 2A | 0.049 | ||
| IGFBP4 | insulin-like growth factor binding protein 4 | 0.049 | ||
| ITGB7 | integrin, beta 7 | 0.049 | Human | |
| MAP3K3 | mitogen-activated protein kinase kinase kinase 3 | 0.049 | ||
| FST | follistatin | 0.048 | ||
| MAP1B | microtubule-associated protein 1B | 0.048 | ||
| SH3KBP1 | SH3-domain kinase binding protein 1 | 0.048 | ||
| IL13 | interleukin 13 | 0.048 | ||
| IRF4 | interferon regulatory factor 4 | 0.048 | ||
| HNF1B | HNF1 homeobox B | 0.048 | ||
| HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 | 0.047 | ||
| CASP7 | caspase 7, apoptosis-related cysteine peptidase | 0.047 | ||
| IFNB1 | interferon, beta 1, fibroblast | 0.047 | Human | |
| TCEB2 | transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B) | 0.047 | ||
| PPP1R9B | protein phosphatase 1, regulatory (inhibitor) subunit 9B | 0.047 | ||
| NPPB | natriuretic peptide B | 0.047 | ||
| CCR3 | chemokine (C-C motif) receptor 3 | 0.047 | ||
| HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 0.047 | ||
| DKK3 | dickkopf homolog 3 (Xenopus laevis) | 0.046 | ||
| FBN1 | fibrillin 1 | 0.046 | ||
| LTK | leukocyte receptor tyrosine kinase | 0.046 | ||
| ITGA7 | integrin, alpha 7 | 0.045 | Human | |
| IL5 | interleukin 5 (colony-stimulating factor, eosinophil) | 0.045 | ||
| MCAM | melanoma cell adhesion molecule | 0.045 | ||
| WNT3A | wingless-type MMTV integration site family, member 3A | 0.045 | Mouse | |
| KNG1 | kininogen 1 | 0.045 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.045 | ||
| CD79B | CD79b molecule, immunoglobulin-associated beta | 0.045 | ||
| PVR | poliovirus receptor | 0.045 | ||
| CSF3R | colony stimulating factor 3 receptor (granulocyte) | 0.045 | Human | |
| CD7 | CD7 molecule | 0.045 | ||
| RHOU | ras homolog gene family, member U | 0.045 | ||
| EPHB4 | EPH receptor B4 | 0.045 | Human | |
| TFPI2 | tissue factor pathway inhibitor 2 | 0.045 | ||
| CLIC4 | chloride intracellular channel 4 | 0.045 | ||
| CRIM1 | cysteine rich transmembrane BMP regulator 1 (chordin-like) | 0.045 | ||
| CSNK1E | casein kinase 1, epsilon | 0.045 | ||
| PTK6 | PTK6 protein tyrosine kinase 6 | 0.045 | ||
| ADH1B | alcohol dehydrogenase 1B (class I), beta polypeptide | 0.045 | ||
| ITCH | itchy E3 ubiquitin protein ligase homolog (mouse) | 0.045 | ||
| DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.045 | ||
| F2RL1 | coagulation factor II (thrombin) receptor-like 1 | 0.044 | ||
| PSEN1 | presenilin 1 | 0.044 | Mouse | |
| IL12A | interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) | 0.044 | ||
| LPAR1 | lysophosphatidic acid receptor 1 | 0.044 | ||
| TBX2 | T-box 2 | 0.044 | ||
| SPHK1 | sphingosine kinase 1 | 0.044 | ||
| CAV2 | caveolin 2 | 0.044 | ||
| ITGA6 | integrin, alpha 6 | 0.044 | Human | |
| TIMP1 | TIMP metallopeptidase inhibitor 1 | 0.044 | ||
| TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.044 | ||
| PDGFC | platelet derived growth factor C | 0.043 | Mouse | |
| CLU | clusterin | 0.043 | ||
| FZD8 | frizzled homolog 8 (Drosophila) | 0.043 | ||
| IL21R | interleukin 21 receptor | 0.043 | ||
| SERPINE2 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 | 0.043 | ||
| PDCD6 | programmed cell death 6 | 0.043 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.043 | Human Mouse | |
| ADRB2 | adrenergic, beta-2-, receptor, surface | 0.043 | Human | |
| MSC | musculin | 0.043 | ||
| ARRDC3 | arrestin domain containing 3 | 0.043 | ||
| PLXDC1 | plexin domain containing 1 | 0.043 | ||
| HDAC6 | histone deacetylase 6 | 0.043 | ||
| PREX1 | phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 | 0.043 | ||
| EGF | epidermal growth factor | 0.043 | ||
| AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.042 | Human | |
| NOS2 | nitric oxide synthase 2, inducible | 0.042 | ||
| MMP19 | matrix metallopeptidase 19 | 0.042 | ||
| DEPTOR | DEP domain containing MTOR-interacting protein | 0.042 | ||
| RGS16 | regulator of G-protein signaling 16 | 0.042 | ||
| LY96 | lymphocyte antigen 96 | 0.042 | ||
| IGFBP2 | insulin-like growth factor binding protein 2, 36kDa | 0.042 | ||
| NOTCH3 | notch 3 | 0.041 | ||
| FOXA2 | forkhead box A2 | 0.041 | ||
| CIB1 | calcium and integrin binding 1 (calmyrin) | 0.041 | ||
| HTR1B | 5-hydroxytryptamine (serotonin) receptor 1B | 0.041 | Human | |
| TF | transferrin | 0.041 | ||
| PAPPA | pregnancy-associated plasma protein A, pappalysin 1 | 0.041 | ||
| ARHGDIA | Rho GDP dissociation inhibitor (GDI) alpha | 0.041 | ||
| GIF | gastric intrinsic factor (vitamin B synthesis) | 0.041 | ||
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.041 | ||
| CYTH1 | cytohesin 1 | 0.041 | ||
| IL2 | interleukin 2 | 0.041 | ||
| SLIT3 | slit homolog 3 (Drosophila) | 0.041 | ||
| FGB | fibrinogen beta chain | 0.040 | Human | |
| KCNMA1 | potassium large conductance calcium-activated channel, subfamily M, alpha member 1 | 0.040 | ||
| SOCS5 | suppressor of cytokine signaling 5 | 0.040 | ||
| ALK | anaplastic lymphoma receptor tyrosine kinase | 0.040 | ||
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.040 | ||
| PAK4 | p21 protein (Cdc42/Rac)-activated kinase 4 | 0.040 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.040 | ||
| EPHB3 | EPH receptor B3 | 0.040 | Human | |
| SIGLEC7 | sialic acid binding Ig-like lectin 7 | 0.040 | ||
| SRPX | sushi-repeat containing protein, X-linked | 0.040 | ||
| ITGAX | integrin, alpha X (complement component 3 receptor 4 subunit) | 0.040 | ||
| IL3RA | interleukin 3 receptor, alpha (low affinity) | 0.040 | ||
| MAP4K5 | mitogen-activated protein kinase kinase kinase kinase 5 | 0.040 | ||
| RASGRF1 | Ras protein-specific guanine nucleotide-releasing factor 1 | 0.040 | ||
| MMP3 | matrix metallopeptidase 3 (stromelysin 1, progelatinase) | 0.039 | ||
| RAMP2 | receptor (G protein-coupled) activity modifying protein 2 | 0.039 | ||
| FABP4 | fatty acid binding protein 4, adipocyte | 0.039 | ||
| HSPG2 | heparan sulfate proteoglycan 2 | 0.039 | ||
| BCL3 | B-cell CLL/lymphoma 3 | 0.039 | ||
| PTPRA | protein tyrosine phosphatase, receptor type, A | 0.039 | ||
| LAMA4 | laminin, alpha 4 | 0.039 | ||
| IRS4 | insulin receptor substrate 4 | 0.039 | ||
| LAMB3 | laminin, beta 3 | 0.039 | ||
| CSF1R | colony stimulating factor 1 receptor | 0.039 | ||
| TGFA | transforming growth factor, alpha | 0.039 | ||
| EDN1 | endothelin 1 | 0.039 | ||
| HMGA2 | high mobility group AT-hook 2 | 0.039 | ||
| LRP6 | low density lipoprotein receptor-related protein 6 | 0.039 | Human | |
| CAPRIN2 | caprin family member 2 | 0.039 | ||
| DRD1 | dopamine receptor D1 | 0.039 | Human | |
| PTPRF | protein tyrosine phosphatase, receptor type, F | 0.039 | ||
| ADAM9 | ADAM metallopeptidase domain 9 | 0.039 | Human | |
| CDC42EP2 | CDC42 effector protein (Rho GTPase binding) 2 | 0.039 | ||
| IDE | insulin-degrading enzyme | 0.038 | ||
| ADAM15 | ADAM metallopeptidase domain 15 | 0.038 | Human | |
| MATK | megakaryocyte-associated tyrosine kinase | 0.038 | ||
| MYLK | myosin light chain kinase | 0.038 | ||
| PKP4 | plakophilin 4 | 0.038 | ||
| ANGPT4 | angiopoietin 4 | 0.038 | ||
| SIRT1 | sirtuin 1 | 0.038 | ||
| IL9R | interleukin 9 receptor | 0.038 | ||
| CDX2 | caudal type homeobox 2 | 0.038 | ||
| GCGR | glucagon receptor | 0.038 | ||
| DOK4 | docking protein 4 | 0.038 | ||
| LAMB1 | laminin, beta 1 | 0.037 | ||
| HCK | hemopoietic cell kinase | 0.037 | Human | |
| COL4A3 | collagen, type IV, alpha 3 (Goodpasture antigen) | 0.037 | ||
| CCL22 | chemokine (C-C motif) ligand 22 | 0.037 | ||
| G0S2 | G0/G1switch 2 | 0.037 | ||
| FMOD | fibromodulin | 0.037 | ||
| PTPN21 | protein tyrosine phosphatase, non-receptor type 21 | 0.037 | ||
| AMMECR1 | Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 | 0.037 | ||
| ADAM2 | ADAM metallopeptidase domain 2 | 0.037 | Human | |
| IL15RA | interleukin 15 receptor, alpha | 0.037 | ||
| SPTBN1 | spectrin, beta, non-erythrocytic 1 | 0.037 | ||
| LAMC1 | laminin, gamma 1 (formerly LAMB2) | 0.037 | ||
| IL2RB | interleukin 2 receptor, beta | 0.037 | ||
| DDX4 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 | 0.037 | ||
| TCEB1 | transcription elongation factor B (SIII), polypeptide 1 (15kDa, elongin C) | 0.037 | ||
| FGFR3 | fibroblast growth factor receptor 3 | 0.037 | ||
| HRH1 | histamine receptor H1 | 0.037 | ||
| MAP2 | microtubule-associated protein 2 | 0.036 | ||
| FZD7 | frizzled homolog 7 (Drosophila) | 0.036 | ||
| MGP | matrix Gla protein | 0.036 | ||
| IBTK | inhibitor of Bruton agammaglobulinemia tyrosine kinase | 0.036 | ||
| NOV | nephroblastoma overexpressed gene | 0.036 | ||
| OPRM1 | opioid receptor, mu 1 | 0.036 | ||
| ENPP2 | ectonucleotide pyrophosphatase/phosphodiesterase 2 | 0.036 | ||
| PTHLH | parathyroid hormone-like hormone | 0.036 | ||
| SELPLG | selectin P ligand | 0.036 | ||
| ADAMTS5 | ADAM metallopeptidase with thrombospondin type 1 motif, 5 | 0.036 | ||
| NKG7 | natural killer cell group 7 sequence | 0.036 | ||
| SLCO2A1 | solute carrier organic anion transporter family, member 2A1 | 0.036 | ||
| WT1 | Wilms tumor 1 | 0.035 | ||
| RARG | retinoic acid receptor, gamma | 0.035 | ||
| RGS3 | regulator of G-protein signaling 3 | 0.035 | ||
| SPP1 | secreted phosphoprotein 1 | 0.035 | ||
| ARHGAP5 | Rho GTPase activating protein 5 | 0.035 | ||
| FMR1 | fragile X mental retardation 1 | 0.035 | ||
| ITGB8 | integrin, beta 8 | 0.035 | ||
| SSTR3 | somatostatin receptor 3 | 0.035 | ||
| DPT | dermatopontin | 0.035 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.035 | ||
| CXCL14 | chemokine (C-X-C motif) ligand 14 | 0.035 | ||
| KLF13 | Kruppel-like factor 13 | 0.035 | ||
| PDE10A | phosphodiesterase 10A | 0.034 | ||
| PYY | peptide YY | 0.034 | ||
| MYD88 | myeloid differentiation primary response gene (88) | 0.034 | ||
| COL6A2 | collagen, type VI, alpha 2 | 0.034 | ||
| FGF18 | fibroblast growth factor 18 | 0.034 | ||
| EFNA5 | ephrin-A5 | 0.034 | Human | |
| COL6A3 | collagen, type VI, alpha 3 | 0.034 | ||
| CCL1 | chemokine (C-C motif) ligand 1 | 0.034 | ||
| SOX9 | SRY (sex determining region Y)-box 9 | 0.034 | ||
| INPPL1 | inositol polyphosphate phosphatase-like 1 | 0.034 | ||
| HTR4 | 5-hydroxytryptamine (serotonin) receptor 4 | 0.034 | Human | |
| EREG | epiregulin | 0.034 | ||
| MMP7 | matrix metallopeptidase 7 (matrilysin, uterine) | 0.034 | ||
| CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.034 | ||
| RAMP3 | receptor (G protein-coupled) activity modifying protein 3 | 0.034 | ||
| TMEM47 | transmembrane protein 47 | 0.034 | ||
| CXCR6 | chemokine (C-X-C motif) receptor 6 | 0.034 | ||
| CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) | 0.033 | ||
| HLA-DOA | major histocompatibility complex, class II, DO alpha | 0.033 | ||
| FES | feline sarcoma oncogene | 0.033 | ||
| INHBB | inhibin, beta B | 0.033 | ||
| ABO | ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase) | 0.033 | ||
| CRIPAK | cysteine-rich PAK1 inhibitor | 0.033 | ||
| SEMA3C | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C | 0.033 | ||
| DPEP3 | dipeptidase 3 | 0.033 | ||
| CMA1 | chymase 1, mast cell | 0.033 | ||
| INO80B | INO80 complex subunit B | 0.033 | ||
| CALCR | calcitonin receptor | 0.033 | ||
| MCF2 | MCF.2 cell line derived transforming sequence | 0.033 | ||
| PRR5L | proline rich 5 like | 0.033 | ||
| PRDM8 | PR domain containing 8 | 0.033 | ||
| PLA2G2D | phospholipase A2, group IID | 0.033 | ||
| ZBTB16 | zinc finger and BTB domain containing 16 | 0.033 | ||
| SLIT2 | slit homolog 2 (Drosophila) | 0.033 | ||
| SEMA6A | sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A | 0.033 | ||
| STRADB | STE20-related kinase adaptor beta | 0.033 | ||
| F13A1 | coagulation factor XIII, A1 polypeptide | 0.033 | ||
| VIPR2 | vasoactive intestinal peptide receptor 2 | 0.033 | ||
| COL13A1 | collagen, type XIII, alpha 1 | 0.033 | ||
| SDS | serine dehydratase | 0.033 | ||
| C7 | complement component 7 | 0.033 | ||
| MMS22L | MMS22-like, DNA repair protein | 0.033 | ||
| IGF2 | insulin-like growth factor 2 (somatomedin A) | 0.033 | Human Mouse | |
| ICA1 | islet cell autoantigen 1, 69kDa | 0.033 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.033 | ||
| FOXO1 | forkhead box O1 | 0.033 | ||
| EPHA5 | EPH receptor A5 | 0.033 | Human | |
| CD163 | CD163 molecule | 0.033 | ||
| MLN | motilin | 0.033 | ||
| RUNX1 | runt-related transcription factor 1 | 0.032 | ||
| SFRP2 | secreted frizzled-related protein 2 | 0.032 | Human Mouse | |
| AKT1S1 | AKT1 substrate 1 (proline-rich) | 0.032 | ||
| RPS6KA2 | ribosomal protein S6 kinase, 90kDa, polypeptide 2 | 0.032 | ||
| MS4A6A | membrane-spanning 4-domains, subfamily A, member 6A | 0.032 | ||
| STAT5B | signal transducer and activator of transcription 5B | 0.032 | ||
| FOXF1 | forkhead box F1 | 0.032 | ||
| HTR1A | 5-hydroxytryptamine (serotonin) receptor 1A | 0.032 | Human | |
| CUL2 | cullin 2 | 0.032 | ||
| SERPINB2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 | 0.032 | ||
| PTH | parathyroid hormone | 0.032 | ||
| C8A | complement component 8, alpha polypeptide | 0.032 | ||
| CH25H | cholesterol 25-hydroxylase | 0.032 | ||
| RET | ret proto-oncogene | 0.032 | ||
| SFRP5 | secreted frizzled-related protein 5 | 0.032 | Human | |
| CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 | 0.032 | ||
| RBMS3 | RNA binding motif, single stranded interacting protein 3 | 0.032 | ||
| SHANK2 | SH3 and multiple ankyrin repeat domains 2 | 0.032 | ||
| HOXD9 | homeobox D9 | 0.032 | ||
| IRF8 | interferon regulatory factor 8 | 0.032 | ||
| SLC16A3 | solute carrier family 16, member 3 (monocarboxylic acid transporter 4) | 0.032 | ||
| AP2A1 | adaptor-related protein complex 2, alpha 1 subunit | 0.032 | ||
| SERPINA5 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 | 0.032 | ||
| PFN1 | profilin 1 | 0.032 | ||
| OR2AG1 | olfactory receptor, family 2, subfamily AG, member 1 | 0.032 | ||
| C4BPB | complement component 4 binding protein, beta | 0.031 | ||
| CALD1 | caldesmon 1 | 0.031 | ||
| CARD10 | caspase recruitment domain family, member 10 | 0.031 | ||
| TBX21 | T-box 21 | 0.031 | ||
| GP1BA | glycoprotein Ib (platelet), alpha polypeptide | 0.031 | ||
| GNLY | granulysin | 0.031 | ||
| SH2D2A | SH2 domain containing 2A | 0.031 | ||
| F2R | coagulation factor II (thrombin) receptor | 0.031 | ||
| TNS3 | tensin 3 | 0.031 | ||
| WNT7A | wingless-type MMTV integration site family, member 7A | 0.031 | ||
| ITIH3 | inter-alpha (globulin) inhibitor H3 | 0.031 | ||
| TMC6 | transmembrane channel-like 6 | 0.031 | ||
| PID1 | phosphotyrosine interaction domain containing 1 | 0.031 | ||
| ALOX5 | arachidonate 5-lipoxygenase | 0.031 | ||
| CTSD | cathepsin D | 0.031 | ||
| FGF4 | fibroblast growth factor 4 | 0.031 | Human | |
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.031 | ||
| CNTN1 | contactin 1 | 0.031 | ||
| EDIL3 | EGF-like repeats and discoidin I-like domains 3 | 0.031 | Human | |
| SAMD4B | sterile alpha motif domain containing 4B | 0.031 | ||
| KLF1 | Kruppel-like factor 1 (erythroid) | 0.031 | ||
| AXIN1 | axin 1 | 0.030 | ||
| IL12RB1 | interleukin 12 receptor, beta 1 | 0.030 | ||
| PARD6G | par-6 partitioning defective 6 homolog gamma (C. elegans) | 0.030 | ||
| PMP22 | peripheral myelin protein 22 | 0.030 | ||
| APCS | amyloid P component, serum | 0.030 | ||
| F3 | coagulation factor III (thromboplastin, tissue factor) | 0.030 | ||
| ADRB3 | adrenergic, beta-3-, receptor | 0.030 | Human | |
| TAPBP | TAP binding protein (tapasin) | 0.030 | ||
| SPP2 | secreted phosphoprotein 2, 24kDa | 0.030 | ||
| ADAM18 | ADAM metallopeptidase domain 18 | 0.030 | Human | |
| IGF1 | insulin-like growth factor 1 (somatomedin C) | 0.030 | ||
| SRCIN1 | SRC kinase signaling inhibitor 1 | 0.030 | ||
| CLDN5 | claudin 5 | 0.030 | ||
| ICOSLG | inducible T-cell co-stimulator ligand | 0.030 | ||
| GNMT | glycine N-methyltransferase | 0.030 | ||
| ARAF | v-raf murine sarcoma 3611 viral oncogene homolog | 0.030 | ||
| TNK2 | tyrosine kinase, non-receptor, 2 | 0.030 | ||
| MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.030 | ||
| CDH3 | cadherin 3, type 1, P-cadherin (placental) | 0.030 | ||
| NCSTN | nicastrin | 0.030 | ||
| PRODH2 | proline dehydrogenase (oxidase) 2 | 0.030 | ||
| STK10 | serine/threonine kinase 10 | 0.030 | ||
| TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 | 0.030 | ||
| STK38 | serine/threonine kinase 38 | 0.030 | ||
| ANKRD1 | ankyrin repeat domain 1 (cardiac muscle) | 0.030 | ||
| PDX1 | pancreatic and duodenal homeobox 1 | 0.030 | ||
| HAND2 | heart and neural crest derivatives expressed 2 | 0.030 | ||
| ILK | integrin-linked kinase | 0.030 | ||
| TACR3 | tachykinin receptor 3 | 0.030 | ||
| LTBR | lymphotoxin beta receptor (TNFR superfamily, member 3) | 0.030 | Human |